Keiichi Matsuzaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keiichi Matsuzaki has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Yusuke Suzuki
Department of Nephrology Juntendo University Faculty of Medicine Tokyo Japan
6 shared publications Takashi Kawamura
Department of Preventive Services, Kyoto University School of Public Health, Kyoto, Japan
5 shared publications- Keiichi Yamamoto
Information Technology Center, Wakayama Medical University, Wakayama, Japan
4 shared publications Mami Ishida
4 shared publications- Takashi Kawamura
Department of Preventive Services, School of Public Health, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan
4 shared publications - Daisuke Kobayashi
Kyoto University Health Service, Yoshida-Honmachi, Sakyo-ku, Kyoto 606-8501, Japan
3 shared publications
Latest Publications
- Open Access
- 27 September 2026
- Published by Springer Nature in Clinical and Experimental Nephrology
- p. 1-9
The prevalence of IgA nephropathy in Japan: results from a nationwide survey
Background: Precise epidemiological statistics regarding IgA nephropathy (IgAN) are essential for healthcare resource allocation and optimal therapeutic management. However, a nationwide epidemiological study has not been conducted in Japan over the past twenty years. Methods: We conducted a mail-based survey targeting departments at hospitals to estimate the annual numbers of patients with IgAN in 2022. Departments were selected using stratified random sampling based on specialty and hospital size, and a total of 2148 departments (nephrology, pediatrics, and urology) were included in the analysis. The overall and sex-specific annual numbers of patients with IgAN were estimated, along with the number of patients with high disease activity. The corresponding prevalence was calculated using these estimates, divided by the midyear population of Japan in 2022. Results: A total of 702 departments responded to the survey representing an overall response rate of 32.7%. The estimated numbers of patients with IgAN were 103,800 (95% confidence interval [CI] 83,431124,170), including 50,160 men (95% CI 40,034–60,287) and 53,640 women (95% CI 42,79964,481). The annual prevalence of IgAN was 83.1 per 100,000 population (men: 82.6 women: 83.6), with a male-to-female ratio of 0.99. The estimated numbers of IgAN patients with high disease activity were 15,646 (95% CI 12,46418,828). Conclusions: This nationwide survey provides updated estimates of the prevalence of IgAN and the number of the IgAN patients with high disease activity in Japan. The prevalence of IgAN has risen substantially over the past twenty years.
- 27 September 2026
- Published by Springer Nature in Clinical and Experimental Nephrology
- p. 1-9
Open AccessThe prevalence of IgA nephropathy in Japan: results from a nationwide survey
Background: Precise epidemiological statistics regarding IgA nephropathy (IgAN) are essential for healthcare resource allocation and optimal therapeutic management. However, a nationwide epidemiological study has not been conducted in Japan over the past twenty years. Methods: We conducted a mail-based survey targeting departments at hospitals to estimate the annual numbers of patients with IgAN in 2022. Departments were selected using stratified random sampling based on specialty and hospital size, and a total of 2148 departments (nephrology, pediatrics, and urology) were included in the analysis. The overall and sex-specific annual numbers of patients with IgAN were estimated, along with the number of patients with high disease activity. The corresponding prevalence was calculated using these estimates, divided by the midyear population of Japan in 2022. Results: A total of 702 departments responded to the survey representing an overall response rate of 32.7%. The estimated numbers of patients with IgAN were 103,800 (95% confidence interval [CI] 83,431124,170), including 50,160 men (95% CI 40,034–60,287) and 53,640 women (95% CI 42,79964,481). The annual prevalence of IgAN was 83.1 per 100,000 population (men: 82.6 women: 83.6), with a male-to-female ratio of 0.99. The estimated numbers of IgAN patients with high disease activity were 15,646 (95% CI 12,46418,828). Conclusions: This nationwide survey provides updated estimates of the prevalence of IgAN and the number of the IgAN patients with high disease activity in Japan. The prevalence of IgAN has risen substantially over the past twenty years.
- Open Access
- 17 September 2026
- Published by Springer Nature in BMC Oral Health
Community periodontal index based screening findings and healthcare expenditures: a 7-year cohort study of male employees in Japan
Background: The global economic burden of dental diseases, particularly periodontitis, is substantial, with growing evidence linking these conditions to systemic diseases such as diabetes and cardiovascular diseases. Although international studies have demonstrated that periodontal treatment can mitigate medical costs, comprehensive research examining the relationship among oral health, healthcare expenditures, and systemic disease onset is still scarce, particularly in Japan. Therefore, this study examined the associations among oral health, medical and dental expenditures, and the incidence of lifestyle-related diseases, using annual health checkup data. Methods: This 7-year cohort study analyzed data from 467 male employees who participated in annual health and dental check-ups from 2007 to 2014. Participants were categorized into CPI ≥ 3 group (at least one tooth) and CPI < 3 group based on the community periodontal index. We compared baseline characteristics and healthcare expenditures (medical, dental, pharmaceutical and total healthcare) between two groups. Longitudinal changes in glycated hemoglobin (HbA1c) levels were evaluated using a mixed model for repeated measures. Results: Participants in the CPI ≥ 3 group ( n = 87) were significantly older than the CPI < 3 group ( n = 380). Regarding median annual expenditures, dental expenditure (¥12,760 vs. ¥7,030; p = 0.01), and total healthcare expenditure (¥97,030 vs. ¥51,415; p = 0.03) were significantly higher in the CPI ≥ 3 group in unadjusted GLM analyses, whereas medical expenditure (¥41,160 vs. ¥21,770; p = 0.11) was not. In age adjusted analyses, only dental expenditure remained independently and significantly higher (mean difference: ¥12,692; p = 0.03). No significant difference in HbA1c trajectories or the risk of exceeding an HbA1c threshold of 5.6% or 6.5% was observed between the two groups. Conclusion: Our findings suggest that a CPI-based screening finding of ≥ 3 is independently associated with higher long-term dental expenditures. Promoting corporate CPI-based screening as a low-threshold, population-level marker has the potential to serve as a strategy for identifying individuals at risk for elevated healthcare burdens.
- 17 September 2026
- Published by Springer Nature in BMC Oral Health
Open AccessCommunity periodontal index based screening findings and healthcare expenditures: a 7-year cohort study of male employees in Japan
Background: The global economic burden of dental diseases, particularly periodontitis, is substantial, with growing evidence linking these conditions to systemic diseases such as diabetes and cardiovascular diseases. Although international studies have demonstrated that periodontal treatment can mitigate medical costs, comprehensive research examining the relationship among oral health, healthcare expenditures, and systemic disease onset is still scarce, particularly in Japan. Therefore, this study examined the associations among oral health, medical and dental expenditures, and the incidence of lifestyle-related diseases, using annual health checkup data. Methods: This 7-year cohort study analyzed data from 467 male employees who participated in annual health and dental check-ups from 2007 to 2014. Participants were categorized into CPI ≥ 3 group (at least one tooth) and CPI < 3 group based on the community periodontal index. We compared baseline characteristics and healthcare expenditures (medical, dental, pharmaceutical and total healthcare) between two groups. Longitudinal changes in glycated hemoglobin (HbA1c) levels were evaluated using a mixed model for repeated measures. Results: Participants in the CPI ≥ 3 group ( n = 87) were significantly older than the CPI < 3 group ( n = 380). Regarding median annual expenditures, dental expenditure (¥12,760 vs. ¥7,030; p = 0.01), and total healthcare expenditure (¥97,030 vs. ¥51,415; p = 0.03) were significantly higher in the CPI ≥ 3 group in unadjusted GLM analyses, whereas medical expenditure (¥41,160 vs. ¥21,770; p = 0.11) was not. In age adjusted analyses, only dental expenditure remained independently and significantly higher (mean difference: ¥12,692; p = 0.03). No significant difference in HbA1c trajectories or the risk of exceeding an HbA1c threshold of 5.6% or 6.5% was observed between the two groups. Conclusion: Our findings suggest that a CPI-based screening finding of ≥ 3 is independently associated with higher long-term dental expenditures. Promoting corporate CPI-based screening as a low-threshold, population-level marker has the potential to serve as a strategy for identifying individuals at risk for elevated healthcare burdens.
- Open Access
- 18 September 2025
- Published by Wiley in Nephrology
- Vol. 30 (9) , e70128
Glomerular Galactose‐Deficient IgA1 Deposition in 192 Autopsy Cases in Japan
Aim: Glomerular IgA deposition is incidentally observed in asymptomatic individuals; however, it remains unclear whether these cases represent a preclinical stage of IgA nephropathy (IgAN). We aimed to address this question by staining kidney samples from autopsy cases with the anti‐galactose‐deficient IgA1 (Gd‐IgA1: the key effector molecule in the pathogenesis of IgAN) antibody, KM55. Methods: Kidney samples from 192 autopsy cases in Japan were stained with anti‐IgA antibody and KM55. The deposition of complement C3, IgG and IgM in glomeruli, as well as the histological findings and clinical data were analysed in cases positive for glomerular IgA. Results: Glomerular IgA deposition was detected in 13 cases (6.8%), all of which were stained with KM55. Of 10 cases with available urinary data prior to admission, six did not have abnormal urinary findings. 7 of 13 were positive for glomerular Gd‐IgA1 alone without obvious histological changes. Glomerular IgG and IgM were detected in 1 of 13 and 5 of 13 cases, respectively. 2 of 13 were positive for glomerular C3, with one showing mesangial proliferation. Conclusion: Our results indicate that asymptomatic cases with glomerular IgA deposition may frequently include subclinical IgAN, characterised by glomerular deposition of Gd‐IgA1 (KM55‐positive) without prominent histopathological changes or obvious clinical symptoms.
- 18 September 2025
- Published by Wiley in Nephrology
- Vol. 30 (9) , e70128
Open AccessGlomerular Galactose‐Deficient IgA1 Deposition in 192 Autopsy Cases in Japan
Aim: Glomerular IgA deposition is incidentally observed in asymptomatic individuals; however, it remains unclear whether these cases represent a preclinical stage of IgA nephropathy (IgAN). We aimed to address this question by staining kidney samples from autopsy cases with the anti‐galactose‐deficient IgA1 (Gd‐IgA1: the key effector molecule in the pathogenesis of IgAN) antibody, KM55. Methods: Kidney samples from 192 autopsy cases in Japan were stained with anti‐IgA antibody and KM55. The deposition of complement C3, IgG and IgM in glomeruli, as well as the histological findings and clinical data were analysed in cases positive for glomerular IgA. Results: Glomerular IgA deposition was detected in 13 cases (6.8%), all of which were stained with KM55. Of 10 cases with available urinary data prior to admission, six did not have abnormal urinary findings. 7 of 13 were positive for glomerular Gd‐IgA1 alone without obvious histological changes. Glomerular IgG and IgM were detected in 1 of 13 and 5 of 13 cases, respectively. 2 of 13 were positive for glomerular C3, with one showing mesangial proliferation. Conclusion: Our results indicate that asymptomatic cases with glomerular IgA deposition may frequently include subclinical IgAN, characterised by glomerular deposition of Gd‐IgA1 (KM55‐positive) without prominent histopathological changes or obvious clinical symptoms.
- Open Access
- 7 January 2025
- Published by Oxford University Press (OUP) in Journal of Occupational Health
- Vol. 67 (1)
Effectiveness of recommendations in promoting the use of mobile health applications in health guidance: a randomized controlled trial
Objectives: Use of commercially available mobile health (mHealth) applications in supporting lifestyle improvements has become popular in recent years. However, the effectiveness of advice promoting the use of such applications based on individual behavioral goals in a health guidance setting remains unclear. This study explored how guiding participants of the Specific Health Guidance (SHG) program, a Japanese public health initiative to prevent cardiovascular disease, to use commercially available mHealth applications impacted their application usage, lifestyle habits, and cardiovascular risk factors. Methods: In this multicenter, randomized, open-label, parallel-group comparison study, 156 individuals with a history of SHG participation and who were engaged in the Motivational Health Guidance program (a type of SHG) in 2021 were assigned to intervention (n = 76) or control (n = 80) groups. Whereas both groups received standard guidance, the intervention group also received recommendations for mHealth applications based on their individual behavioral goals. The participants’ application usage, behavioral changes, and body weight were assessed after 3 months, with health checkup data evaluated after 1 year. Results: The proportion of mHealth application users after 3 months was significantly higher in the intervention group (68.4%) than in the control group (40.0%). The intervention group also reported a significantly greater weekly frequency of mHealth application usage. Moreover, the intervention group reported a significantly decreased change in triglyceride levels after 1 year compared with the control group. Conclusions: Recommending commercially available mHealth applications in a health guidance setting significantly increased the number of mHealth application users and their frequency of use.
- 7 January 2025
- Published by Oxford University Press (OUP) in Journal of Occupational Health
- Vol. 67 (1)
Open AccessEffectiveness of recommendations in promoting the use of mobile health applications in health guidance: a randomized controlled trial
Objectives: Use of commercially available mobile health (mHealth) applications in supporting lifestyle improvements has become popular in recent years. However, the effectiveness of advice promoting the use of such applications based on individual behavioral goals in a health guidance setting remains unclear. This study explored how guiding participants of the Specific Health Guidance (SHG) program, a Japanese public health initiative to prevent cardiovascular disease, to use commercially available mHealth applications impacted their application usage, lifestyle habits, and cardiovascular risk factors. Methods: In this multicenter, randomized, open-label, parallel-group comparison study, 156 individuals with a history of SHG participation and who were engaged in the Motivational Health Guidance program (a type of SHG) in 2021 were assigned to intervention (n = 76) or control (n = 80) groups. Whereas both groups received standard guidance, the intervention group also received recommendations for mHealth applications based on their individual behavioral goals. The participants’ application usage, behavioral changes, and body weight were assessed after 3 months, with health checkup data evaluated after 1 year. Results: The proportion of mHealth application users after 3 months was significantly higher in the intervention group (68.4%) than in the control group (40.0%). The intervention group also reported a significantly greater weekly frequency of mHealth application usage. Moreover, the intervention group reported a significantly decreased change in triglyceride levels after 1 year compared with the control group. Conclusions: Recommending commercially available mHealth applications in a health guidance setting significantly increased the number of mHealth application users and their frequency of use.
- Open Access
- 7 January 2025
- Published by Oxford University Press (OUP) in Journal of Occupational Health
- Vol. 67 (1)
Demographic and work-related correlates of general and workplace loneliness among employees in Japan: a large-scale descriptive cross-sectional study
Objectives: There has been limited research on demographic and work-related characteristics of general and workplace loneliness. The present descriptive cross-sectional study aimed to determine the demographic and work-related correlates of general and workplace loneliness in a general working population of Japan. Methods: We recruited 25 000 persons aged 20 years or older and employed by a company, organization, or government agency. We limited the sample to only employees for this analysis. Demographic and work-related characteristics were assessed by a self-report questionnaire. General and workplace loneliness were measured by single-item questions and dichotomized. Results: A total of 24 021 respondents were subjected for the analysis. Prevalences of general and workplace loneliness were 9.0% and 8.3%, respectively. Those who responded “others” or refused to answer a gender question (possibly gender minority), were middle-aged, not married, with a low household income, working in the manufacturing sector (compared with some service sectors), and reporting long working hours were associated with both general and workplace loneliness. Middle-aged groups and work hours were significantly associated with workplace loneliness after adjusting for general loneliness. Conclusions: Common demographic and work-related correlates were found for both general and workplace loneliness. Middle age and working long hours may be factors for workplace loneliness, independent of general loneliness, in Japan.
- 7 January 2025
- Published by Oxford University Press (OUP) in Journal of Occupational Health
- Vol. 67 (1)
Open AccessDemographic and work-related correlates of general and workplace loneliness among employees in Japan: a large-scale descriptive cross-sectional study
Objectives: There has been limited research on demographic and work-related characteristics of general and workplace loneliness. The present descriptive cross-sectional study aimed to determine the demographic and work-related correlates of general and workplace loneliness in a general working population of Japan. Methods: We recruited 25 000 persons aged 20 years or older and employed by a company, organization, or government agency. We limited the sample to only employees for this analysis. Demographic and work-related characteristics were assessed by a self-report questionnaire. General and workplace loneliness were measured by single-item questions and dichotomized. Results: A total of 24 021 respondents were subjected for the analysis. Prevalences of general and workplace loneliness were 9.0% and 8.3%, respectively. Those who responded “others” or refused to answer a gender question (possibly gender minority), were middle-aged, not married, with a low household income, working in the manufacturing sector (compared with some service sectors), and reporting long working hours were associated with both general and workplace loneliness. Middle-aged groups and work hours were significantly associated with workplace loneliness after adjusting for general loneliness. Conclusions: Common demographic and work-related correlates were found for both general and workplace loneliness. Middle age and working long hours may be factors for workplace loneliness, independent of general loneliness, in Japan.
- Open Access
- 1 January 2024
- Published by Japan Society for Occupational Health in Environmental and Occupational Health Practice
- Vol. 6 (1)
Influence of previous health guidance history: impact and limitations of a single health guidance session
Objectives: Metabolic syndrome (MS) is a significant health concern in the working-age population. Since 2008, Japan has mandated health insurers to implement Specific Health Checkups to identify individuals with MS and preliminary groups, making Specific Health Guidance (SHG) compulsory for these groups. People receiving SHG multiple times is increasing as it is conducted as an annual public program. Therefore, we evaluated the influence of a health guidance history on the effectiveness of subsequent guidance. Methods: Using data from 10,191 participants in the 2017 Motivational Health Guidance (a type of SHG involving a single session), this longitudinal study assessed the changes in health checkup findings from 2017 to 2018. Participants were categorized based on their previous year's (2016) SHG eligibility and participation: Group 1 (n=3,903) met the 2016 SHG criteria and participated, Group 2 (n=2,305) met the criteria but did not participate, and Group 3 (n=3,983) had no MS risk factors and did not need to participate in the 2016 SHG. Results: The entire cohort and Groups 2 and 3 exhibited significant weight loss after 1 year. Group 1 showed a significant negative association, with a 3% (odds ratio [OR] 0.64; 95% confidence interval [CI], 0.55–0.75) and 5% body weight loss (OR 0.66; 95% CI, 0.54–0.81) than Group 3. Men in Group 1 showed a significant association with new-onset MS (OR 2.56; 95% CI, 1.93–3.40). Conclusions: The findings suggest that participants with a history of health guidance in the previous year may have low rates of achieving weight loss and a high incidence of new-onset MS after 1 year.
- 1 January 2024
- Published by Japan Society for Occupational Health in Environmental and Occupational Health Practice
- Vol. 6 (1)
Open AccessInfluence of previous health guidance history: impact and limitations of a single health guidance session
Objectives: Metabolic syndrome (MS) is a significant health concern in the working-age population. Since 2008, Japan has mandated health insurers to implement Specific Health Checkups to identify individuals with MS and preliminary groups, making Specific Health Guidance (SHG) compulsory for these groups. People receiving SHG multiple times is increasing as it is conducted as an annual public program. Therefore, we evaluated the influence of a health guidance history on the effectiveness of subsequent guidance. Methods: Using data from 10,191 participants in the 2017 Motivational Health Guidance (a type of SHG involving a single session), this longitudinal study assessed the changes in health checkup findings from 2017 to 2018. Participants were categorized based on their previous year's (2016) SHG eligibility and participation: Group 1 (n=3,903) met the 2016 SHG criteria and participated, Group 2 (n=2,305) met the criteria but did not participate, and Group 3 (n=3,983) had no MS risk factors and did not need to participate in the 2016 SHG. Results: The entire cohort and Groups 2 and 3 exhibited significant weight loss after 1 year. Group 1 showed a significant negative association, with a 3% (odds ratio [OR] 0.64; 95% confidence interval [CI], 0.55–0.75) and 5% body weight loss (OR 0.66; 95% CI, 0.54–0.81) than Group 3. Men in Group 1 showed a significant association with new-onset MS (OR 2.56; 95% CI, 1.93–3.40). Conclusions: The findings suggest that participants with a history of health guidance in the previous year may have low rates of achieving weight loss and a high incidence of new-onset MS after 1 year.
- Open Access
- 21 December 2023
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 11, e46725
A Pragmatic Method to Integrate Data From Preexisting Cohort Studies Using the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model: Case Study
Background: In recent years, many researchers have focused on the use of legacy data, such as pooled analyses that collect and reanalyze data from multiple studies. However, the methodology for the integration of preexisting databases whose data were collected for different purposes has not been established. Previously, we developed a tool to efficiently generate Study Data Tabulation Model (SDTM) data from hypothetical clinical trial data using the Clinical Data Interchange Standards Consortium (CDISC) SDTM. Objective: This study aimed to design a practical model for integrating preexisting databases using the CDISC SDTM. Methods: Data integration was performed in three phases: (1) the confirmation of the variables, (2) SDTM mapping, and (3) the generation of the SDTM data. In phase 1, the definitions of the variables in detail were confirmed, and the data sets were converted to a vertical structure. In phase 2, the items derived from the SDTM format were set as mapping items. Three types of metadata (domain name, variable name, and test code), based on the CDISC SDTM, were embedded in the Research Electronic Data Capture (REDCap) field annotation. In phase 3, the data dictionary, including the SDTM metadata, was outputted in the Operational Data Model (ODM) format. Finally, the mapped SDTM data were generated using REDCap2SDTM version 2. Results: SDTM data were generated as a comma-separated values file for each of the 7 domains defined in the metadata. A total of 17 items were commonly mapped to 3 databases. Because the SDTM data were set in each database correctly, we were able to integrate 3 independently preexisting databases into 1 database in the CDISC SDTM format. Conclusions: Our project suggests that the CDISC SDTM is useful for integrating multiple preexisting databases.
- 21 December 2023
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 11, e46725
Open AccessA Pragmatic Method to Integrate Data From Preexisting Cohort Studies Using the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model: Case Study
Background: In recent years, many researchers have focused on the use of legacy data, such as pooled analyses that collect and reanalyze data from multiple studies. However, the methodology for the integration of preexisting databases whose data were collected for different purposes has not been established. Previously, we developed a tool to efficiently generate Study Data Tabulation Model (SDTM) data from hypothetical clinical trial data using the Clinical Data Interchange Standards Consortium (CDISC) SDTM. Objective: This study aimed to design a practical model for integrating preexisting databases using the CDISC SDTM. Methods: Data integration was performed in three phases: (1) the confirmation of the variables, (2) SDTM mapping, and (3) the generation of the SDTM data. In phase 1, the definitions of the variables in detail were confirmed, and the data sets were converted to a vertical structure. In phase 2, the items derived from the SDTM format were set as mapping items. Three types of metadata (domain name, variable name, and test code), based on the CDISC SDTM, were embedded in the Research Electronic Data Capture (REDCap) field annotation. In phase 3, the data dictionary, including the SDTM metadata, was outputted in the Operational Data Model (ODM) format. Finally, the mapped SDTM data were generated using REDCap2SDTM version 2. Results: SDTM data were generated as a comma-separated values file for each of the 7 domains defined in the metadata. A total of 17 items were commonly mapped to 3 databases. Because the SDTM data were set in each database correctly, we were able to integrate 3 independently preexisting databases into 1 database in the CDISC SDTM format. Conclusions: Our project suggests that the CDISC SDTM is useful for integrating multiple preexisting databases.
- Open Access
- 11 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
A Pragmatic Method to Integrate Data from Pre-existing Cohort Studies using the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM): Practical use of REDCap2SDTM (Preprint)
BACKGROUND In recent years, many researchers have focused on legacy data utilization, such as pooled analyses that collect and re-analyze data from multiple studies. However, the methodology for the integration of pre-existing databases whose data were collected for different purposes has not been established. Previously, we developed a tool to efficiently generate Study Data Tabulation Model (SDTM) data from hypothetical clinical trial data using the Clinical Data Interchange Standards Consortium (CDISC) SDTM. OBJECTIVE To design a practical model for integrating pre-existing databases using the CDISC SDTM. METHODS Data integration was performed in three phases: i) confirmation of the variables, ii) SDTM mapping, and iii) generation of the SDTM data. In phase 1, the definitions of the variables in detail were confirmed, and the datasets were converted to vertical datasets. In phase 2, the items derived from the SDTM format were set as mapping items. Three types of metadata (domain name, variable name, and test code), based on the CDISC SDTM, were embedded in the REDCap field annotation. In phase 3, the data dictionary, including the SDTM metadata, were output in the Operational Data Model (ODM) format. Finally, the mapped SDTM were generated using REDCap2SDTM v2. RESULTS SDTM data were generated as a comma-separated values file for each of the seven domains defined in the metadata. Twenty-two items were commonly mapped to three databases. Because the SDTM data were set in each database correctly, we were able to integrate three independently pre-existing databases into one database in the CDISC SDTM format. CONCLUSIONS Our project suggests that the CDISC SDTM is useful for integrating multiple pre-existing databases.
- 11 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Pragmatic Method to Integrate Data from Pre-existing Cohort Studies using the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM): Practical use of REDCap2SDTM (Preprint)
BACKGROUND In recent years, many researchers have focused on legacy data utilization, such as pooled analyses that collect and re-analyze data from multiple studies. However, the methodology for the integration of pre-existing databases whose data were collected for different purposes has not been established. Previously, we developed a tool to efficiently generate Study Data Tabulation Model (SDTM) data from hypothetical clinical trial data using the Clinical Data Interchange Standards Consortium (CDISC) SDTM. OBJECTIVE To design a practical model for integrating pre-existing databases using the CDISC SDTM. METHODS Data integration was performed in three phases: i) confirmation of the variables, ii) SDTM mapping, and iii) generation of the SDTM data. In phase 1, the definitions of the variables in detail were confirmed, and the datasets were converted to vertical datasets. In phase 2, the items derived from the SDTM format were set as mapping items. Three types of metadata (domain name, variable name, and test code), based on the CDISC SDTM, were embedded in the REDCap field annotation. In phase 3, the data dictionary, including the SDTM metadata, were output in the Operational Data Model (ODM) format. Finally, the mapped SDTM were generated using REDCap2SDTM v2. RESULTS SDTM data were generated as a comma-separated values file for each of the seven domains defined in the metadata. Twenty-two items were commonly mapped to three databases. Because the SDTM data were set in each database correctly, we were able to integrate three independently pre-existing databases into one database in the CDISC SDTM format. CONCLUSIONS Our project suggests that the CDISC SDTM is useful for integrating multiple pre-existing databases.
- Open Access
- 12 September 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (18) , 11466
Association between 3-Year Repetitive Isolated Hematuria and eGFR Deterioration in an Apparently Healthy Population: A Retrospective Cohort Study
Microscopic hematuria is being increasingly recognized as a major indicator of kidney deterioration. Persistent hematuria may better detect estimated glomerular filtration rate (eGFR) deterioration and potential glomerulonephritis. We conducted a retrospective cohort study to investigate the associations between persistent hematuria: the frequency or consistency of positive dipstick hematuria defined by the preceding 3 years urinalyses, and eGFR deterioration over 5 years and abnormal urinalyses suggesting potential glomerulonephritis (hematuria 1+ or higher, 2+ or higher, proteinuria, and hematuria and proteinuria) 5 years later, among adult participants with positive dipstick hematuria at baseline in a large-scale Japanese health checkup setting (n = 2104). There was no significant association between persistent hematuria and eGFR deterioration over 5 years. The higher the frequency of preceding hematuria, the greater the RR of hematuria 5 years later; RRs of hematuria with preceding thrice, twice, or once hematuria were 3.64 [95% CI, 3.11–4.25], 2.97 [95% CI, 2.52–3.51], or 1.91 [95% CI, 1.58–2.30] for “hematuria 1+ or higher,” and 7.13 [95% CI, 5.17–9.83], 4.26 [95% CI, 3.02–6.02], or 2.23 [95% CI, 1.52–3.27] for “hematuria 2+ or higher”. The presence of both hematuria and proteinuria 5 years later was only associated with preceding thrice hematuria (RR: 2.35 [95% CI, 1.37–4.03]). In conclusion, persistent hematuria for 3 years was associated with hematuria and proteinuria that were suggesting glomerulonephritis, but not associated with eGFR deterioration over 5 years. Multiple dipstick urinalyses over years can add some values to detect potential glomerulonephritis as an early sign of chronic kidney diseases.
- 12 September 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (18) , 11466
Open AccessAssociation between 3-Year Repetitive Isolated Hematuria and eGFR Deterioration in an Apparently Healthy Population: A Retrospective Cohort Study
Microscopic hematuria is being increasingly recognized as a major indicator of kidney deterioration. Persistent hematuria may better detect estimated glomerular filtration rate (eGFR) deterioration and potential glomerulonephritis. We conducted a retrospective cohort study to investigate the associations between persistent hematuria: the frequency or consistency of positive dipstick hematuria defined by the preceding 3 years urinalyses, and eGFR deterioration over 5 years and abnormal urinalyses suggesting potential glomerulonephritis (hematuria 1+ or higher, 2+ or higher, proteinuria, and hematuria and proteinuria) 5 years later, among adult participants with positive dipstick hematuria at baseline in a large-scale Japanese health checkup setting (n = 2104). There was no significant association between persistent hematuria and eGFR deterioration over 5 years. The higher the frequency of preceding hematuria, the greater the RR of hematuria 5 years later; RRs of hematuria with preceding thrice, twice, or once hematuria were 3.64 [95% CI, 3.11–4.25], 2.97 [95% CI, 2.52–3.51], or 1.91 [95% CI, 1.58–2.30] for “hematuria 1+ or higher,” and 7.13 [95% CI, 5.17–9.83], 4.26 [95% CI, 3.02–6.02], or 2.23 [95% CI, 1.52–3.27] for “hematuria 2+ or higher”. The presence of both hematuria and proteinuria 5 years later was only associated with preceding thrice hematuria (RR: 2.35 [95% CI, 1.37–4.03]). In conclusion, persistent hematuria for 3 years was associated with hematuria and proteinuria that were suggesting glomerulonephritis, but not associated with eGFR deterioration over 5 years. Multiple dipstick urinalyses over years can add some values to detect potential glomerulonephritis as an early sign of chronic kidney diseases.
- Open Access
- 6 September 2022
- Published by MDPI AG in Healthcare
- Vol. 10 (9) , 1704
Identification of High-Risk Groups in Urinalysis: Lessons from the Longitudinal Analysis of Annual Check-Ups
Background: For effective screening in urinalysis, information on high-risk groups is needed; however, there is a lack of evidence in young adults in particular. The aim of this study was to provide information on urinalysis in young adults and to identify high-risk groups of urinalyses using multi-year data obtained from annual large-scale check-ups. Method: We used annual health check-up data collected from 2011 to 2016 at Kyoto University in Japan. Eligible participants were those aged 18–39 years who underwent annual health check-ups for four consecutive years between 2011 and 2016. We conducted descriptive analyses and calculated the risk ratios (RRs) for urinary abnormalities in the fourth year of urinalysis. Results: In total, 13,640 participants (10,877 men, 79.7%) met the eligibility criteria. The mean prevalence rates of proteinuria, haematuria and glucosuria were 1.61% (men: 1.63%; women: 1.53%), 1.48% (men: 0.53%; women: 5.22%) and 0.46% (men: 0.52%; women: 0.25%), respectively. Participants with urinary abnormalities at least once in the initial 3 years had a higher risk of urinary abnormalities in the fourth year than participants with no abnormal findings in the initial 3 years; the risk ratios (RRs) of proteinuria, haematuria and glucosuria were 3.5 (95% confidence interval (CI) = 3.2–3.7), 12.2 (95% CI = 11.7–12.7) and 42.6 (95% CI = 37.7–48.1), respectively. The RRs of all urinary abnormalities in the fourth year increased as the frequency of urinary abnormalities over the preceding 3 years increased. In haematuria, differences of the RR were observed between men and women. Conclusion: We clarified the prevalence of urinary abnormalities in young adults and high-risk groups of urinary abnormalities. Our findings support the need for multi-year annual urinalysis.
- 6 September 2022
- Published by MDPI AG in Healthcare
- Vol. 10 (9) , 1704
Open AccessIdentification of High-Risk Groups in Urinalysis: Lessons from the Longitudinal Analysis of Annual Check-Ups
Background: For effective screening in urinalysis, information on high-risk groups is needed; however, there is a lack of evidence in young adults in particular. The aim of this study was to provide information on urinalysis in young adults and to identify high-risk groups of urinalyses using multi-year data obtained from annual large-scale check-ups. Method: We used annual health check-up data collected from 2011 to 2016 at Kyoto University in Japan. Eligible participants were those aged 18–39 years who underwent annual health check-ups for four consecutive years between 2011 and 2016. We conducted descriptive analyses and calculated the risk ratios (RRs) for urinary abnormalities in the fourth year of urinalysis. Results: In total, 13,640 participants (10,877 men, 79.7%) met the eligibility criteria. The mean prevalence rates of proteinuria, haematuria and glucosuria were 1.61% (men: 1.63%; women: 1.53%), 1.48% (men: 0.53%; women: 5.22%) and 0.46% (men: 0.52%; women: 0.25%), respectively. Participants with urinary abnormalities at least once in the initial 3 years had a higher risk of urinary abnormalities in the fourth year than participants with no abnormal findings in the initial 3 years; the risk ratios (RRs) of proteinuria, haematuria and glucosuria were 3.5 (95% confidence interval (CI) = 3.2–3.7), 12.2 (95% CI = 11.7–12.7) and 42.6 (95% CI = 37.7–48.1), respectively. The RRs of all urinary abnormalities in the fourth year increased as the frequency of urinary abnormalities over the preceding 3 years increased. In haematuria, differences of the RR were observed between men and women. Conclusion: We clarified the prevalence of urinary abnormalities in young adults and high-risk groups of urinary abnormalities. Our findings support the need for multi-year annual urinalysis.